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A RAPID disappearance oftumour tissue is usually accompanied by an increased
urinary excretion of metabolites (Eliel et al., 1950; Homburger, Bonner and
Fishman, 1952; Fenninger, Waterhouse and Kentmann, 1953; Spencer, Green-
berg and Laszlo, 1954; Sandberg, Cartwright and Wintrobe, 1956; Krakoff,
1957). To give an idea of the quantitative relationships, the following mean
figures are given (abstracted from Waterhouse, Terepka and Sherman, 1955):
1 kg. fat free tumour tissue contains about 85 per cent water, ± 24 g.
(_ 1700 mMol) Nitrogen, about 3 g. ( ± 100 mMol) Phosphate and
± 4 g. (- 100 mMol) Potassium.
The rise of the urinary excretion of metabolites depends on the rate of tumour
destruction. In a former publication (Gerbrandy, Hellendoorn and Lokkerbol,
1958) the excess excretion of different metabolites during X-ray irradiation of
5 leukaemic and 3 cancer patients was calculated. A close time-relationship
appeared to exist between the changes in the excretion of metabolites and the
beginning and cessation of tumour loss. The total amount of excess excreted
phosphate agreed reasonably with the clinical estimates of tumour loss and the
ratios between the total excess excretions of phosphate, potassium and uric acid
appeared to be in the range as could be expected from the destruction of tumour
tissue. In this paper the results of our investigations into the effect of cytotoxic
drugs on the urinary excretion of metabolites are published. In these experi-
ments the same relationships have been found as in our experiments with X-ray
irradiation.
METHODS
Six patients with Hodgkin's disease, 3 patients with metastasized carcinoma
(1 mamma, 1 thyroid, 1 unknown) and 1 patient with generalized reticulosarco-
matosis received a diet which was accurately standardized in every case at 2000
to 2500 calories, 15 to 20 g. proteins, ± 600 mg. phosphate, ± 200 mg. calcium,
± 40 mMol potassium and ± 3000 mg. nitrogen a day.
Eight patients received intravenous injections of nitrogen mustard to a total
dose of 25 to 30 mg. in 4 to 12 days; 2 patients received intravenous injections
of triethylenemelamine to a total dose of 18 mg. in 5 days. The injections were
started when a reasonably stable level ofexcretion of metabolites was attained.
The chemical determinations are described in the former publication (Ger-
brandy, Hellendoorn and Lokkerbol, 1958). The nitrogen was determined by aEXCRETION OF METABOLITES DURING TREATMENT
micro-Kjeldahl method. Each patient was weighed 3 times a week at 10 a.m.
always under identical conditions. The rectal temperature was taken 3 times
a day.
RESULTS
Eight patients (5 M. Hodgkin, 1 reticulosarcomatosis and 2 metastasized
carcinoma) were treated with i.v. injections of nitrogen mustard. In Table I the
clinical data are given together with the figures of the changes in the urinary
excretion of phosphate, uric acid, potassium, calcium, urea and creatinine. The
column for the control period contains the figures for the excretion ofmetabolites
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FIG. 1.-Changes in the urinary excretion of metabolites in 7 patients
during treatment with nitrogen mustard.
for a number of days before treatment started; during this period the excretion
of the different metabolites had reached a stable level. The column " metabolic
changes during treatment " comprises the days starting from the beginning of
the injections till the day on which a new equilibrium in excretion had been
reached. Finally the column " period of stabilization " contains the figures for
the excretion of this new equilibrium. The time of observation was only long
enough in 6 patients to reach this new equilibrium. The body weight of each
period represents the last measurement in this period. The mean rectal tempera-
ture of a period was calculated from the highest readings of each day. In Fig. 1
the daily fluctuations of the urinary excretions of metabolites, body weight and
rectal temperature are given of 7 patients. The metabolic changes in the 8th
patient, Mr. K-, were too big to be pictured in this graph; they are given in
Fig. 2.
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HeEXCRETION OF METABOLITES DURING TREATMENT
Two patients (1 M. Hodgkin and 1 metastasized thyroid carcinoma) received
intravenous injections oftriethylenemelamine. In Table II the metabolic changes
are calculated in the same way as in Table I and in Fig. 3 the daily figures for the
urinary excretions of metabolites, body weight and rectal temperature are
depicted.
In the following paragraphs the same 3 relationships will be established as has
been done in our former paper (Gerbrandy, Hellendoorn and Lokkerbol, 1958)
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FIG. 2.-Changes in the urinary excretion ofmetabolites in a patient with generalized
reticulosarcomatosis during treatment with nitrogen mustard.
about X-ray irradiation to 5 leukaemic and 3 cancer patients. For the sake of
clarity the figures of our investigation on the effect of cytotoxic drugs will often
be presented together with the corresponding figures ofouir irradiated patients.
(a) The time-relationship
During treatment with nitrogen mustard and triethylenemelamine the ex-
cretion of metabolites usually started to rise between the 2nd and 3rd day of the
period oftreatment. In Table III the first day ofelevated excretion ofphosphate
and uric acid after commencing therapy is given in all our experiments with X-ray
irradiation and cytotoxic drugs.
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FIG. 3.-Changes in the urinary excretion ofmetabolites in 2 patients
during treatment by intravenous injections of TEM.
TABLE III
First day of increased
excretion after
commencing therapy
Therapy Phosphate
Ro 2
,, . ~~~1
,, . 2
,, . 2
', . 3
9, . 3
HN2 * 2
'9 . 3
', . 3
,, . 2
,, . 2
'9 . 3
,, . 3
,, . I1
T.E.M. . 2
,,P . 2
Uric acid
2
1
2
3
3
4
3
3
2
2
3
2
2
Duration
of increased
excretion in days
29
27
24+
41+
19
16+
16+
22+
15
13
18
12
13
10
2 . 10
4 . 10
U
--- -.-a~ -
Name
Mr. de V-
Mr. M-
Mrs. Z-.
Mrs. v. D
Mr. P-.
Mr. G1-
Mr. A- .
Mr. W-
Miss B-
Miss R-
Mr. R- .
Mr. N-.
Miss 8-
Mr. K-.
Mrs. v. T
Mrs. S-
Diagnosis
Myel. leuk.
9 ,,
Lymph. leuk.
P,,
Retic. sarc.
M. Hodgkin
Metast. carc.
$,,
Retic. sarc.
M. Hodgkin
Metast. care.
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(b) The total excess excretion ofphosphate
According to the findings of Waterhouse, Terepka and Sherman (1955) the
P-content of 1 kg. of tumour tissue is assumed to be as follows: lymphatic leuk-
aemia ± 4-7 g., myeloid leukaemia ± 3-2 g., M. Hodgkin + 2-5 g., reticulosarcoma
± 3.2 g. and carcinoma ± 18 g. With these facts the total loss of tumour tissue
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FIG. 4.-Correlation between calculated tumour loss (total excess excretion of phosphate) andfall of
body weight in 18 patients treated with X-ray irradiation or cytotoxics.
is calculated from the excess excretion ofphosphate. Because ofthe simultaneous
rise of calcium excretion (skeletal breakdown) a correction of the phosphate ex-
cretion had to be made by means of the ratio Ca: P = 2-2: 1. In Fig. 4 the
calculated tumour loss from the excess excretion of P is compared with the fall
of body weight in the same period. A significant correlation appeared to exist in
which a calculated loss of 1 kg. of tumour tissue corresponded with a loss of at
least 2 kg. of body weight.
TABLE IV
Palpable changes
Spleen Liver
Excess Calculated (cm. (cm.
excretion loss of below below
of P tumour costal costal Lymph
Name Diagnosis Treatment (g.) (kg.) margin) margin) glands
Mr.A M.Hodgkin NH2 3.8 15 2- 0 2 0 +++ , +
Mr. W . pJ, . ,, 2-9 .1 1 . 2-> 0 j 0 ++-> +
MissB- . . 1 9 . 05 3 -.0 Notpalp. + i
MissR 19 0.8 Notpalp. ,, +++ Mr. R- . ,, . 1-5 . 06 . 1 -. 0 +& 0
Mr.N Metast. carc. 10 0-6 ,, Notpalp. + ±
MissS- 0.8 04 ,, + +
Mr. K- . Retic. sarc. . 1 2. 2 . 3.5 (Rapid metastasis to all
internal organs)
Mrs.V.T- . M.Hodgkin TEM 4.4 17 6 -. 1 Notpalp.++++ +
Mrs.5- . Metast. carc. . , 0 9 0 5 20-18 12--12 4+ +
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In Table IV the loss of tumour tissue calculated from the excess excretion of P
is compared with other clinical data. The establishment ofa quantitative relation-
ship is impossible, of course, as not enough quantitative criteria of tumour loss
are available. However, the decrease in the size of spleen and liver and the
diminution of glandular swelling are a useful measure of therapeutic effect. It
appears from the figures in Table IV that a certain correlation exists between the
calculated tumour loss and the palpable tumour loss.
(c) The mutual ratio between the exce88 excretion ofmetabolite8
In Table V the excess excretion of different metabolites in the urine during
the period of metabolic changes is calculated in grams and millimols, taking the
excretion in the control period as a base line. In 5 patients the mean rectal
temperature during the control period was higher than 37.50 C. This was accom-
panied by an abnormally high excretion of urea and uric acid. In these cases we
used the excretion level ofthe " period ofstabilization " as a base for calculating
the excess excretion of the different metabolites. The excess excretions of phos-
phate have been corrected for changes in the calcium excretion according to the
ratio calcium: phosphorus - 2-2: 1.
In Table VI the following ratios between the excess excreted metabolites are cal-
culated: Mol P : Mol uric acid, Mol P: Mol K, Mol K gram N (calculated from
urea, uric acid and creatinine), Mol urea: Mol uric acid, gram N (calculated from
urea, uric acid and creatinine): gram P. In 3 cases the excess excretions ofnitro-
gen calculated from the excess excreted amounts or urea, uric acid and creatinine
were checked by a direct determiination of the total nitrogen in the urine; they
differed no more than ± 10 per cent.
DISCUSSION
The same relationship appeared principally to exist between the injection of
nitrogen mustard or triethylenemelamine (TEM) and the excretion ofmetabolites
as that between X-ray irradiation and the excretion of metabolites (Gerbrandy,
Hellendoorn and Lokkerbol, 1958). This is concluded from the following facts:
1. A close time-relationship appeared to exist between the onset of the rise
of metabolites and the commencement of injections (usually a difference of one
day). It is not possible to correlate the end ofthe increase ofthe excretion ofthe
metabolites with clinical data. It appears from the curves of the excretions of
metabolites after injections of nitrogen mustard and TEM that the onset and
rapidity of tumour destruction is practically the same for both substances, pro-
vided both are injected intravenously.
2. A close parallelism existed between the estimated tumour loss, calculated
from the urinary excess excretion ofphosphate, and the two approximate clinical
standards of tumour loss, i.e. (a) the fall of body weight and (b) the diminishing
ofthesize ofanenlarged spleen, liver or lymph glands. As regardsthefallofbody
weight this appeared to be twice as great as the tumour loss calculated from the
excess excretions of phosphate. This will be caused by the loss of extracellular
fluid and the loss of other tissues with a lower phosphate content. Furthermore
the excess excretion ofphosphate will not represent only loss oftumour tissue, as
the injected cytotoxic drugs will also affect other rapid cell-dividing tissues as for
instance bone marrow and such-like. Maybe the excess excretion of 0.8 g. phos-
33
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TABLE V.-The Urinary Excess Excretion of Metabolites During the Period of Metabolic Changes
Name
Mr. A-
Mr. W-
Miss B-*
Miss R-*
Mr. R-*
Mr. N-
Phosphate Uric acid
Diag- Treat- , A-
nosis ment (g.) (mMol) (g.) (mMol)
M. . HN2 . 3,807 123-0 . 3,512 20-9
Hodgkin
2,867 92-S . 3,388 20-2
2,383 77-0 3,450 20-5
,, . ,, . 1,991 64-2 . 3,186 19-0
9, . ,, . 2,240 72-3 2,142 12-8
. Metast. . 969 31-3 . 732 4-4
carc.
Potas-
sium
(mMol)
3-2
Urea N (urea+uric N
Creatinine ac.+creatin. total
(g.) (mMol) (mg.) (g.) (g.)
26-9 449 . -272 . 13-6 . -
48-4 . 23-3
75-0 . 53-3
-29-5 . 25-7
49-6 33-7
3-6 . 28-8
388 .
889 .
429 .
526 .
480 .
-1,912 .
+1,200*.
+98*.
+1,800*.
-396 .
11-3
26-4
13-1
17-1
13-6
12-3
Miss . ,,.,,. 773 25-0. 1,404 8-4. -10-4. 36-4 607. -208. 17-5 . -
Mr.K-* . Retic. 13,802 445 . 15,880 94-7 519-0 . 271-7 4.520 +1,650*. 132-5
sarc.
Mrs. v.T-*. M. .TEM. 2,073 66-0 . 5,687 33-6 . -27-5 . 78-0 1,299 . +1,749*. 38-9 . 34-2
Hodgkin
Mrs. S- Metast. . ,, . 908 29-3 . 1,727 10-3 . 7-7 . 24-8 412 . -77 . 12-1 . 13-4
carc.
* The period of metabolic changes is compared with the after period of stabilization because of fever in the control
period. On account ofthe gradual fall of creatinine excretion a ± excretion of creatinine is noted in these cases.
TABLE VI.-The Urinary Excess Excretion ofMetabolites During the Period ofMetabolic Changes
Diagnosis
. M. Hodgkin
. Metast. carc.
.Retic. sarc.
Mol P: Mol P:
Mol uric Mol K
Treatment acid
HN2 . 5-9 . 40-7
,, . 4-6 . 1-9
,, . 3-5 . 1-0
,, . 3-4 . *
,, . 5.7 . 1-5
-,, 7-1 . 8-7
,, . 3-0 . -3*
, . 4-7 . 0-9
Mrs. v. T- . M. Hodgkin . TEM .
Mrs. S. . Metast. carc. .
2-0
2-8 3-8
Mol K: Urea Mol urea: Gram N Urea
Gram N Uric ac. Mol uric Gram P Uric ac.
Creatin. acid LCreatin.
0-2 . 21-5 . 3-6
4-3 . 19-2 . 3-9
2-9 . 43-4 . 11-1
-* . 22-6 . 6-6
2-9 . 43-9 . 7-6
0-3 3 109-0 14-0
- * . 72-3 . 22-6
3-9 9 47-7 7 9-6
0-6
38-7
40-0
18-8
13-3
* Fall of potassium excretion during the period of metabolic changes.
phate in Miss S- with no perceptible clinical effect from the nitrogen mustard
stems largely from the destruction of non-tumorous tissue.
3. A close parallel exists between the rise and fall ofdifferent metabolites such
as phosphate, uric acid, urea and potassium.
4. The ratios between the excess excretion ofthe different metabolites did not
differfundamentally from the ratios found after X-ray irradiation. The differences
between the individual experiments with cytotoxic drugs, however, were greater
than between those with X-ray irradiation. This may be caused by the fact, that
the cytotoxic drugs affected the whole body, and the X-rays mainly the tumour
tissue. The closest agreement existed between the ratios Mol P: Mol uric acid in
the experiments with irradiation and cytotoxic drugs; in the irradiation experi-
ments this ratio varied between 2-1 and 5-0 (mean 3-7) and in the experiments
with cytotoxics the ratio varied between 2-0 and 7-1 (mean 4-3). These ratios
are to be expected in breakdown of tumour tissue.
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Name
Mr. A-
Mr. W-
Miss B-
Miss R-
Mr. R-
Mr. N-
Miss 8-
Mr. K-EXCRETION OF METABOLITES DURING TREATMENT
The ratio Mol P: Mol K has to be about 1 in tumour tissue. In our experi-
ments with irradiation this ratio varied between 0 5 and 1-4 (mean 0.8). However,
in only 4 of our 10 experiments with cytotoxics was this near 1; in 3 cases the
ratio was much higher and in the other experiments the K-excretion had fallen
during a rise of the other metabolites. It is possible that intravenous injections
of cytotoxics affect the excretion of adrenal hormones and consequently the
excretion of potassium. The variation in the ratio Mol K: gram N in the experi-
ments with cytotoxics were too large to allow conclusions to be drawn.
In one respect the metabolic changes after injection ofcytotoxic drugs differed
from these after irradiation i.e. in .he ratio gram N: gram P. According to
Waterhouse, Terepka and ShermaiL (1955) this ratio amounts to about 15 in
normal protoplasm but varies in leukaemic, sarcomatous and Hodgkin tissue
usually between 5 and 15 and in carcinomatous tissue between 8 and 22. Our
figures in the experiments with irradiation varied between 1-7 and 7-2 (mean 3-8)
but in the experiments with cytotoxics this ratio varied between 3-6 and 23-6
(mean 11.1). The difference between the two sets of experiments has to be ex-
plained partly by the larger P-content of leukaemic cells than of Hodgkin and
carcinomatous tissue and partly by the destruction of non-tumorous tissues with
a relatively low P-content by the cytotoxic drugs.
In the experiments with cytotoxic drugs the same gradual fall of creatinine
excretion and of serum creatinine was seen as in the irradiation experiments. We
could not demonstrate a correlation between the fall of creatinine excretion and
the fall of body weight. As contrasted with the irradiation experiments, an in-
jection of cytotoxics was usually followed by a rise of calcium excretion (with the
exception of Mrs. v. T- with M. Hodgkin who started with an elevated calcium
excretion of 340 mg. a day). The cytotoxic drugs therefore usually also affect
the bones to some extent.
As in the patients with chronic myeloid leukaemia, the excretion of uric acid
in several patients with Hodgkin's disease was abnormally high during the control
period. The phosphate excretion however, was normal during these periods. This
reflects presumably the nearly total re-utilization of phosphate and the non- or
only partial re-utilization of uric acid during an increased turnover of tumour
cells. The excretion of both metabolites usually rises during the breakdow-n of
tumour tissue but during the period of stabilization afterwards the excretion of
uric acid falls below the control level and the phosphate excretion returns to
about the control level. Assuming an inhibition of tumour growth by nitrogen
mustard and TEM as in our irradiation experiments, the rise ofexcretion ofphos-
phate and uric acid during the intravenous injections probably reflects the amount
of metabolites originating from the normal metabolism of tumour cells that
cannot be incorporated into new tumour cells. In this respect the case of Mr. K-
with an extremely rapidly growing generalized reticulosarcomatosis seems to be
interesting (Fig. 2). During the period of after-control the level of phosphate
excretion fell for 3 days to zero but the excretion ofuric acid stayed at an elevated
level ofabout 700 mg. a day. Presumably allthe phosphate available was required
to be incorporated into the new tumour tissue, in contrast to the uric acid.
SUMMARY
In 10 cancer patients (6 Hodgkin's disease, 3 metastasized carcinoma, 1
generalized reticulosarcoma), who were on a standardized low-protein diet, the
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urinary excretion ofphosphate, uric acid, potassium, calcium, urea and creatinine
was investigated during intravenous injections of nitrogen mustard (8 patients)
and triethylenemelamine (2 patients). The effect of injections of cytotoxics on
the excretions of metabolites appeared to be principally the same as of X-ray
irradiation. This is concluded from the following facts:
1. A close time-relationship appeared to exist between the onset of the rise
of metabolites and the commencement of injections (usually a difference of one
day).
2. A close parallel existed between the estimated tumour loss, calculated from
the urinary excess excretion ofphosphate, and two approximate clinical standards
of tumour loss, i.e. a fall of body weight and a diminishing of the size of an en-
larged spleen, liver or lymph glands.
3. A close parallel existed between the rise and fall of the excretion of cell
metabolites such as phosphate, uric acid, potassium and urea.
4. The ratios between the total excess excretions of phosphate and uric acid
agreed with those found after X-ray irradiation and appeared to be in the range
as could be expected from the destruction oftumour tissue. The excess excretions
of potassium and nitrogen compared to phosphate, however, fell behind those
after X-ray irradiation.
From the experiments with injections of cytotoxics as with X-ray irradiation
a nearly total re-utilization of phosphate and a non- or only partial re-utilization
of uric acid in growing tumour tissue were concluded.
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